Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials

AIM: The aim of this study was to summarize the characteristics, efficacy, and safety of vesicular monoamine transporter-2 (VMAT-2) inhibitors for treating tardive dyskinesia (TD). MATERIALS AND METHODS: We conducted a literature search in PubMed, Cochrane Database, and ClinicalTrials.gov, screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Solmi, Marco, Pigato, Giorgio, Kane, John M, Correll, Christoph U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958944/
https://www.ncbi.nlm.nih.gov/pubmed/29795977
http://dx.doi.org/10.2147/DDDT.S133205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958944/
https://www.ncbi.nlm.nih.gov/pubmed/29795977
http://dx.doi.org/10.2147/DDDT.S133205

Ejemplares similares